Clinical evaluation of a novel method for the measurement of prostate-specific antigen, AccuPSATM, as a predictor of 5-year biochemical recurrence-free survival after radical prostatectomy: results of a pilot study

Simultaneous Detection of Single Molecules and Singulated Ensembles of Molecules Enables Immunoassays with Broad Dynamic Range

(2011) David M. Rissin et al.   ANALYTICAL CHEMISTRY

Predictive and Prognostic Models in Radical Prostatectomy Candidates: A Critical Analysis of the Literature

(2010) Giovanni Lughezzani et al.   EUROPEAN UROLOGY

Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations

(2010) David M Rissin et al.   NATURE BIOTECHNOLOGY

Prognostic Significance of Undetectable Ultrasensitive Prostate-specific Antigen Nadir After Radical Prostatectomy

(2010) Sung Kyu Hong et al.   UROLOGY

Prognostic Implications of an Undetectable Ultrasensitive Prostate-Specific Antigen Level after Radical Prostatectomy

(2009) Michael L. Eisenberg et al.   EUROPEAN UROLOGY

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

(2009) Ian M. Thompson et al.   JOURNAL OF UROLOGY

Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy

(2009) C. S. Thaxton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Does Benign Prostatic Tissue Contribute to Measurable PSA Levels After Radical Prostatectomy?

(2009) Guilherme Godoy et al.   UROLOGY

Prostate Cancer–Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical Prostatectomy

(2008) Bruce J. Trock   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION